よむ、つかう、まなぶ。
04資料2-1_森野委員提出資料（おたふくかぜワクチンファクトシート第２版） (50 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_73851.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第34回 6／19）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
meningitis following measles-mumps-rubella vaccination in the United Kingdom. Am J Epidemiol
2007; 165(6): 704–9.
131.
Black S, Shinefield H, Ray P, et al. Risk of hospitalization because of aseptic meningitis after
measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety
Datalink (VSD) Project. Pediatr Infect Dis J 1997; 16(5): 500–3.
132.
Muta H, Nagai T, Ito Y, Ihara T, Nakayama T. Effect of age on the incidence of aseptic
meningitis following immunization with monovalent mumps vaccine. Vaccine 2015; 33(45): 6049–53.
133.
Ozaki T, Goto Y, Nishimura N, et al. Effects of a Public Subsidy Program for Mumps Vaccine
on Reducing the Disease Burden in Nagoya City, Japan. Jpn J Infect Dis 2019; 72(2): 106–11.
134.
Ki M, Park T, Yi SG, Oh JK, Choi B. Risk analysis of aseptic meningitis after measles-mumps-
rubella vaccination in Korean children by using a case-crossover design. Am J Epidemiol 2003; 157(2):
158–65.
135.
Farrington P, Pugh S, Colville A, et al. A new method for active surveillance of adverse events
from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 1995; 345(8949):
567–9.
136.
da Silveira CM, Kmetzsch CI, Mohrdieck R, Sperb AF, Prevots DR. The risk of aseptic
meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with
measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997. Int J Epidemiol 2002; 31(5): 978–82.
137.
Shinefield H, Black S, Digilio L, et al. Evaluation of a quadrivalent measles, mumps, rubella
and varicella vaccine in healthy children. Pediatr Infect Dis J 2005; 24(8): 665–9.
138.
da Cunha SS, Rodrigues LC, Barreto ML, Dourado I. Outbreak of aseptic meningitis and
mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain. Vaccine
50
2007; 165(6): 704–9.
131.
Black S, Shinefield H, Ray P, et al. Risk of hospitalization because of aseptic meningitis after
measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety
Datalink (VSD) Project. Pediatr Infect Dis J 1997; 16(5): 500–3.
132.
Muta H, Nagai T, Ito Y, Ihara T, Nakayama T. Effect of age on the incidence of aseptic
meningitis following immunization with monovalent mumps vaccine. Vaccine 2015; 33(45): 6049–53.
133.
Ozaki T, Goto Y, Nishimura N, et al. Effects of a Public Subsidy Program for Mumps Vaccine
on Reducing the Disease Burden in Nagoya City, Japan. Jpn J Infect Dis 2019; 72(2): 106–11.
134.
Ki M, Park T, Yi SG, Oh JK, Choi B. Risk analysis of aseptic meningitis after measles-mumps-
rubella vaccination in Korean children by using a case-crossover design. Am J Epidemiol 2003; 157(2):
158–65.
135.
Farrington P, Pugh S, Colville A, et al. A new method for active surveillance of adverse events
from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 1995; 345(8949):
567–9.
136.
da Silveira CM, Kmetzsch CI, Mohrdieck R, Sperb AF, Prevots DR. The risk of aseptic
meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with
measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997. Int J Epidemiol 2002; 31(5): 978–82.
137.
Shinefield H, Black S, Digilio L, et al. Evaluation of a quadrivalent measles, mumps, rubella
and varicella vaccine in healthy children. Pediatr Infect Dis J 2005; 24(8): 665–9.
138.
da Cunha SS, Rodrigues LC, Barreto ML, Dourado I. Outbreak of aseptic meningitis and
mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain. Vaccine
50